Insights on the human microbiome and its xenobiotic metabolism: What is known about its effects on human physiology?

Expert Opinion on Drug Metabolism and Toxicology

Volumn 11, Issue 3, 2015, Pages 411-425

  Tralau, Tewes ^a   Sowada, Juliane ^a   Luch, Andreas ^a  

^a FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

Author keywords

Bacterial degradation; CYP; Entero endocrine crosstalk; Gut; Microbiome; Phase I metabolism; Skin; Xenobiotic metabolism

Indexed keywords

XENOBIOTIC AGENT;

BACTERIAL METABOLISM; COMMUNITY DYNAMICS; DYSBIOSIS; HUMAN; MICROBIAL COMMUNITY; MICROBIOME; NONHUMAN; ORGANISMAL INTERACTION; PATHOPHYSIOLOGY; REVIEW; XENOBIOTIC METABOLISM; ANIMAL; ENDOCRINE SYSTEM; GASTROINTESTINAL TRACT; METABOLISM; MICROBIOLOGY; MICROFLORA; PHYSIOLOGY;

BACTERIA (MICROORGANISMS); EUKARYOTA;

ANIMALS; ENDOCRINE SYSTEM; GASTROINTESTINAL TRACT; HUMANS; MICROBIOTA; XENOBIOTICS;

EID: 84922983227     PISSN: 17425255     EISSN: 17447607     Source Type: Journal    
DOI: 10.1517/17425255.2015.990437     Document Type: Review

References (182)

1. Wallace BD, Redinbo MR. The human microbiome is a source of therapeutic drug targets. Curr Opin Chem Biol 2013;17(3):379-84
2. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010;464(7285):59-65
3. Arumugam M, Raes J, Pelletier E, et al. Enterotypes of the human gut microbiome. Nature 2011;473(7346):174-80
4. Turnbaugh PJ, Ley RE, Hamady M, et al. The human microbiome project. Nature 2007;449(7164):804-10
5. Doré J, Simren M, Buttle L, et al. Hot topics in gut microbiota. United European Gastroenterol J 2013;1(5):311-38
6. Peterson J, Garges S, Giovanni M, et al. The NIH human microbiome project. Genome Res 2009;19(12):2317-23
7. Koren O, Goodrich JK, Cullender TC, et al. Host remodeling of the gut microbiome and metabolic changes during pregnancy. Cell 2012;150(3):470-80
8. Bezirtzoglou E, Stavropoulou E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe 2011;17(6):369-74
9. Bezirtzoglou E, Tsiotsias A, Welling GW. Microbiota profile in feces of breast- and formula-fed newborns by using fluorescence in situ hybridization (FISH). Anaerobe 2011;17(6):478-82
10. Koenig JE, Spor A, Scalfone N, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci USA 2011;108(S1):4578-85
11. Clemente JC, Ursell LK, Parfrey LW, et al. The Impact of the gut microbiota on human health: an integrative view. Cell 2012;148(6):1258-70
12. Blottière HM, de Vos WM, Ehrlich SD, et al. Human intestinal metagenomics: state of the art and future. Curr Opin Microbiol 2013;16(3):232-9
13. Dominguez-Bello MG, Costello EK, Contreras M, et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA 2010;107(26):11971-5
14. Capone KA, Dowd SE, Stamatas GN, et al. Diversity of the human skin microbiome early in life. J Invest Dermatol 2011;131(10):2026-32
15. Claus SP, Ellero SL, Berger B, et al. Colonization-induced host-gut microbial metabolic interaction. MBio 2011;2(2):e00271-10
16. El Aidy S, van Baarlen P, Derrien M, et al. Temporal and spatial interplay of microbiota and intestinal mucosa drive establishment of immune homeostasis in conventionalized mice. Mucosal Immunol 2012;5(5):567-79
17. Roeselers G, Bouwman J, Venema K, et al. The human gastrointestinal microbiota - an unexplored frontier for pharmaceutical discovery. Pharmacol Res 2012;66(6):443-7
18. Lo Cascio RG, Ninonuevo MR, Freeman SL, et al. Glycoprofiling of bifidobacterial consumption of human milk oligosaccharides demonstrates strain specific, preferential consumption of small chain glycans secreted in early human lactation. J Agric Food Chem 2007;55(22):8914-19
19. Bevins C, Salzman N. The potter's wheel: the host's role in sculpting its microbiota. Cell Mol Life Sci 2011;68(22):3675-85
20. Bry L, Falk PG, Midtvedt T, et al. A model of host-microbial interactions in an open mammalian ecosystem. Science 1996;273(5280):1380-3
21. Hooper LV, Xu J, Falk PG, et al. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc Natl Acad Sci USA 1999;96(17):9833-8
22. Licandro-Seraut H, Scornec H, Pedron T, et al. Functional genomics of Lactobacillus casei establishment in the gut. Proc Natl Acad Sci USA 2014;111(30):E3101-9
23. Topping DL, Clifton PM. Short-chain fatty acids and human colonic function: roles of resistant starch and nonstarch polysaccharides. Physiol Rev 2001;81(3):1031-64
24. Gill SR, Pop M, Deboy RT, et al. Metagenomic analysis of the human distal gut microbiome. Science 2006;312(5778):1355-9
25. Cantarel BL, Lombard V, Henrissat B. Complex carbohydrate utilization by the healthy human microbiome. PLoS One 2012;7(6):e28742
26. Li K, Bihan M, Yooseph S, et al. Analyses of the microbial diversity across the human microbiome. PLoS One 2012;7(6):e32118
27. Li K, Bihan M, Methe BA. Analyses of the stability and core taxonomic memberships of the human microbiome. PLoS One 2013;8(5):e63139
28. Savage DC. Microbial ecology of the gastrointestinal tract. Annu Rev Microbiol 1977;31:107-33
29. Eckburg PB, Bik EM, Bernstein CN, et al. Diversity of the human intestinal microbial flora. Science 2005;308(5728):1635-8
30. Collison M, Hirt RP, Wipat A, et al. Data mining the human gut microbiota for therapeutic targets. Brief Bioinform 2012;13(6):751-68
31. Grice EA, Kong HH, Renaud G, et al. A diversity profile of the human skin microbiota. Genome Res 2008;18(7):1043-50
32. Grice EA, Kong HH, Conlan S, et al. Topographical and temporal diversity of the human skin microbiome. Science 2009;324(5931):1190-2
33. Mathieu A, Delmont TO, Vogel TM, et al. Life on human surfaces: skin metagenomics. PLoS One 2013;8(6):e65288
34. Kong HH. Skin microbiome: genomicsbased insights into the diversity and role of skin microbes. Trends Mol Med 2011;17(6):320-8
35. Hannigan GD, Grice EA. Microbial ecology of the skin in the era of metagenomics and molecular microbiology. Cold Spring Harb Perspect Med 2013;3(12):a015362
36. Faust K, Sathirapongsasuti JF, Izard J, et al. Microbial co-occurrence relationships in the human microbiome. PLoS Comput Biol 2012;8(7):e1002606
37. Costello EK, Lauber CL, Hamady M, et al. Bacterial community variation in human body habitats across space and time. Science 2009;326(5960):1694-7
38. Beebe K, Sampey B, Watkins SM, et al. Understanding the apothecaries within: the necessity of a systematic approach for defining the chemical output of the human microbiome. Clin Transl Sci 2014;7(1):74-81
39. Ng KM, Ferreyra JA, Higginbottom SK, et al. Microbiota-liberated host sugars facilitate post-antibiotic expansion of enteric pathogens. Nature 2013;502(7469):96-9
40. Christensen GJ, Bruggemann H. Bacterial skin commensals and their role as host guardians. Benef Microbes 2014;5(2):201-15
41. Montalto M, D'Onofrio F, Gallo A, et al. Intestinal microbiota and its functions. Dig Liver Dis Suppl 2009;3(2):30-4
42. Jorth P, Turner KH, Gumus P, et al. Metatranscriptomics of the human oral microbiome during health and disease. MBio 2014;5(2):e01012-14
43. Kostic AD, Chun E, Robertson L, et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe 2013;14(2):207-15
44. Rubinstein MR, Wang X, Liu W, et al. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/beta-catenin signaling via its FadA adhesin. Cell Host Microbe 2013;14(2):195-206
45. El Rakaiby M, Dutilh BE, Rizkallah MR, et al. Pharmacomicrobiomics: the impact of human microbiome variations on systems pharmacology and personalized therapeutics. Omics 2014;18(7):402-14
46. Belcheva A, Irrazabal T, Robertson SJ, et al. Gut microbial metabolism drives transformation of msh2-deficient colon epithelial cells. Cell 2014;158(2):288-99
47. Arthur JC, Perez-Chanona E, Muhlbauer M, et al. Intestinal inflammation targets cancer-inducing activity of the microbiota. Science 2012;338(6103):120-3
48. Zackular JP, Baxter NT, Iverson KD, et al. The gut microbiome modulates colon tumorigenesis. MBio 2013;4(6):e00692-13
49. Turnbaugh PJ, Ley RE, Mahowald MA, et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006;444(7122):1027-31
50. Ley RE. Obesity and the human microbiome. Curr Opin Gastroenterol 2010;26(1):5-11
51. Ravussin Y, Koren O, Spor A, et al. Responses of gut microbiota to diet composition and weight loss in lean and obese mice. Obesity(Silver Spring) 2012;20(4):738-47
52. Liou AP, Paziuk M, Luevano JM Jr, et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Sci Transl Med 2013;5(178):178ra41
53. Cani PD. Crosstalk between the gut microbiota and the endocannabinoid system: impact on the gut barrier function and the adipose tissue. Clin Microbiol Infect 2012;18(S4):50-3
54. O'Mahony SM, Clarke G, Borre YE, et al. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res 2015;277:32-48
55. Gonzalez A, Stombaugh J, Lozupone C, et al. The mind-body-microbial continuum. Dialogues Clin Neurosci 2011;13(1):55-62
56. Neufeld KM, Kang N, Bienenstock J, et al. Reduced anxiety-like behavior and central neurochemical change in germfree mice. Neurogastroenterol Motil 2011;23(3):255-e119
57. Hsiao EY, McBride SW, Hsien S, et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 2013;155(7):1451-63
58. Zeisel SH, da Costa KA. Choline: an essential nutrient for public health. Nutr Rev 2009;67(11):615-23
59. Ackermann D, Schütze H. The formation of trimethylamine by Bacterium prodigiosum. Zentralb Physiol 1910;24:210-11
60. Tralau T, Lafite P, Levy C, et al. An internal reaction chamber in dimethylglycine oxidase provides efficient protection from exposure to toxic formaldehyde. J Biol Chem 2009;284(26):17826-34
61. Craciun S, Balskus EP. Microbial conversion of choline to trimethylamine requires a glycyl radical enzyme. Proc Natl Acad Sci USA 2012;109(52):21307-12
62. Mac Fabe DF, Cain NE, Boon F, et al. Effects of the enteric bacterial metabolic product propionic acid on object-directed behavior, social behavior, cognition, and neuroinflammation in adolescent rats: relevance to autism spectrum disorder. Behav Brain Res 2011;217(1):47-54
63. Bravo JA, Forsythe P, Chew MV, et al. Ingestion of Lactobacillus strain regulates emotional behavior and central GABA receptor expression in a mouse via the vagus nerve. Proc Natl Acad Sci USA 2011;108(38):16050-5
64. Mac Fabe DF. Short-chain fatty acid fermentation products of the gut microbiome: implications in autism spectrum disorders. Microb Ecol Health Dis 2012;23:19260-83
65. Ramezani A, Raj DS. The gut microbiome, kidney disease, and targeted interventions. J Am Soc Nephrol 2014;25(4):657-70
66. Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature 2007;449(7164):819-26
67. Lai Y, Di Nardo A, Nakatsuji T, et al. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nat Med 2009;15(12):1377-82
68. Gallo RL, Nakatsuji T. Microbial symbiosis with the innate immune defense system of the skin. J Invest Dermatol 2011;131(10):1974-80
69. Naik S, Bouladoux N, Wilhelm C, et al. Compartmentalized control of skin immunity by resident commensals. Science 2012;337(6098):1115-19
70. Cotter PD, Ross RP, Hill C. Bacteriocins - a viable alternative to antibiotics? Nat Rev Microbiol 2013;11(2):95-105
71. Alexeyev OA. Bacterial landscape of human skin: seeing the forest for the trees. Exp Dermatol 2013;22(7):443-6
72. Maheshwari A, Thuluvath PJ. Endocrine diseases and the liver. Clin Liver Dis 2011;15(1):55-67
73. Wong JM, de Souza R, Kendall CW, et al. Colonic health: fermentation and short chain fatty acids. J Clin Gastroenterol 2006;40(3):235-43
74. Samuel BS, Shaito A, Motoike T, et al. Effects of the gut microbiota on host adiposity are modulated by the shortchain fatty-acid binding G proteincoupled receptor, Gpr41. Proc Natl Acad Sci USA 2008;105(43):16767-72
75. Rath CM, Dorrestein PC. The bacterial chemical repertoire mediates metabolic exchange within gut microbiomes. Curr Opin Microbiol 2012;15(2):147-54
76. Cani PD, Everard A, Duparc T. Gut microbiota, enteroendocrine functions and metabolism. Curr Opin Pharmacol 2013;13(6):935-40
77. Clarke G, Stilling RM, Kennedy PJ, et al. Minireview: gut microbiota: the neglected endocrine organ. Mol Endocrinol 2014;28(8):1221-38
78. Markle JG, Frank DN, Mortin-Toth S, et al. Sex differences in the gut microbiome drive hormone-dependent regulation of autoimmunity. Science 2013;339(6123):1084-8
79. Flint HJ, Scott KP, Louis P, et al. The role of the gut microbiota in nutrition and health. Nat Rev Gastroenterol Hepatol 2012;9(10):577-89
80. Lin HV, Frassetto A, Kowalik EJ Jr, et al. Butyrate and propionate protect against diet-induced obesity and regulate gut hormones via free fatty acid receptor 3-independent mechanisms. PLoS One 2012;7(4):e35240
81. Heijtz RD, Wang S, Anuar F, et al. Normal gut microbiota modulates brain development and behavior. Proc Natl Acad Sci USA 2011;108(7):3047-52
82. Pessione E. Lactic acid bacteria contribution to gut microbiota complexity: lights and shadows. Front Cell Infect Microbiol 2012;2:86
83. Duda-Chodak A. The inhibitory effect of polyphenols on human gut microbiota. J Physiol Pharmacol 2012;63(5):497-503
84. Etxeberria U, Fernandez-Quintela A, Milagro FI, et al. Impact of polyphenols and polyphenol-rich dietary sources on gut microbiota composition. J Agric Food Chem 2013;61(40):9517-33
85. Parkar SG, Trower TM, Stevenson DE. Fecal microbial metabolism of polyphenols and its effects on human gut microbiota. Anaerobe 2013;23:12-19
86. Haiser HJ, Turnbaugh PJ. Developing a metagenomic view of xenobiotic metabolism. Pharmacol Res 2013;69(1):21-31
87. Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: implications for obesity and diabetes. Clin Chem 2013;59(4):617-28
88. Scharschmidt TC, Fischbach MA. What lives on our skin: ecology, genomics and therapeutic opportunities of the skin microbiome. Drug Discov Today Dis Mech 2013;10(3-4):e83-9
89. Ibrahim M, Anishetty S. A meta-metabolome network of carbohydrate metabolism: interactions between gut microbiota and host. Biochem Biophys Res Commun 2012;428(2):278-84
90. Jacobsen UP, Nielsen HB, Hildebrand F, et al. The chemical interactome space between the human host and the genetically defined gut metabotypes. ISME J 2013;7(4):730-42
91. Gao J, Ellis LB, Wackett LP. The University of Minnesota biocatalysis/biodegradation database: improving public access. Nucleic Acids Res 2010;38(Database issue):D488-91
92. Tralau T, Luch A. The evolution of our understanding of endo-xenobiotic crosstalk and cytochrome P450 regulation and the therapeutic implications. Expert Opin Drug Metab Toxicol 2013;9(12):1541-54
93. Meinl W, Sczesny S, Brigelius-Flohe R, et al. Impact of gut microbiota on intestinal and hepatic levels of phase 2 xenobiotic-metabolizing enzymes in the rat. Drug Metab Dispos 2009;37(6):1179-86
94. Aura AM, Mattila I, Hyotylainen T, et al. Drug metabolome of the simvastatin formed by human intestinal microbiota in vitro. Mol bioSyst 2011;7(2):437-46
95. Nieuwdorp M, Gilijamse PW, Pai N, et al. Role of the microbiome in energy regulation and metabolism. Gastroenterology 2014;146(6):1525-33
96. Rajilić-Stojanović M. Function of the microbiota. Best Pract Res Clin Gastroenterol 2013;27(1):5-16
97. Smillie CS, Smith MB, Friedman J, et al. Ecology drives a global network of gene exchange connecting the human microbiome. Nature 2011;480(7376):241-4
98. Haiser HJ, Gootenberg DB, Chatman K, et al. Predicting and manipulating cardiac drug inactivation by the human gut bacterium Eggerthella lenta. Science 2013;341(6143):295-8
99. Silver S. Genes for all metals - a bacterial view of the periodic table. The 1996 Thom Award Lecture. J Ind Microbiol Biotechnol 1998;20(1):1-12
100. Michalke K, Schmidt A, Huber B, et al. Role of intestinal microbiota in transformation of bismuth and other metals and metalloids into volatile methyl and hydride derivatives in humans and mice. Appl Environ Microbiol 2008;74(10):3069-75
101. Sousa T, Paterson R, Moore V, et al. The gastrointestinal microbiota as a site for the biotransformation of drugs. Int J Pharm 2008;363(1-2):1-25
102. Vorwerk H, Mohr J, Huber C, et al. Utilization of host-derived cysteinecontaining peptides overcomes the restricted sulfur metabolism of Campylobacter jejuni. Mol Microbiol 2014;93(6):1224-45
103. Maurice CF, Haiser HJ, Turnbaugh PJ. Xenobiotics shape the physiology and gene expression of the active human gut microbiome. Cell 2013;152(1-2):39-50
104. Okuda H, Ogura K, Kato A, et al. A possible mechanism of eighteen patient deaths caused by interactions of sorivudine, a new antiviral drug, with oral 5-fluorouracil prodrugs. J Pharmacol Exp Ther 1998;287(2):791-9
105. Mc Connell EL, Fadda HM, Basit AW. Gut instincts: explorations in intestinal physiology and drug delivery. Int J Pharm 2008;364(2):213-26
106. Yoo DH, Kim IS, Le TK, et al. Gut microbiota-mediated drug interactions between Lovastatin and antibiotics. Drug Metab Dispos 2014;42(9):1508-13
107. Clayton TA, Baker D, Lindon JC, et al. Pharmacometabonomic identification of a significant host-microbiome metabolic interaction affecting human drug metabolism. Proc Natl Acad Sci USA 2009;106(34):14728-33
108. Bezirtzoglou EE. Intestinal cytochromes P450 regulating the intestinal microbiota and its probiotic profile. Microb Ecol Health Dis 2012;23:18370-9
109. Jia ZY, Xia Y, Tong D, et al. Module-based functional pathway enrichment analysis of a protein-protein interaction network to study the effects of intestinal microbiota depletion in mice. Mol Med Rep 2014;9(6):2205-12
110. Fierer N, Hamady M, Lauber CL, et al. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci USA 2008;105(46):17994-9
111. Rosenthal M, Goldberg D, Aiello A, et al. Skin microbiota: microbial community structure and its potential association with health and disease. Infect Genet Evol 2011;11(5):839-48
112. Sowada J, Schmalenberger A, Ebner I, et al. Degradation of benzo[a]pyrene by bacterial isolates from human skin. FEMS Microbiol Ecol 2014;88(1):129-39
113. Platzek T, Lang C, Grohmann G, et al. Formation of a carcinogenic aromatic amine from an azo dye by human skin bacteria in vitro. Hum Exp Toxicol 1999;18(9):552-9
114. Stingley RL, Zou W, Heinze TM, et al. Metabolism of azo dyes by human skin microbiota. J Med Microbiol 2010;59(1):108-14
115. Feng J, Cerniglia CE, Chen H. Toxicological significance of azo dye metabolism by human intestinal microbiota. Front Biosci 2012;4:568-86
116. Gasperotti M, Masuero D, Guella G, et al. Development of a targeted method for twenty-three metabolites related to polyphenol gut microbial metabolism in biological samples, using SPE and UHPLC-ESI-MS/MS. Talanta 2014;128:221-30
117. Dave M, Higgins D, Middha S, et al. The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 2012;160(4):246-57
118. Berry D, Stecher B, Schintlmeister A, et al. Host-compound foraging by intestinal microbiota revealed by singlecell stable isotope probing. Proc Natl Acad Sci USA 2013;110(12):4720-5
119. van Baarlen P, Kleerebezem M, Wells JM. Omics approaches to study host-microbiota interactions. Curr Opin Microbiol 2013;16(3):270-7
120. Lhoste EF, Ouriet V, Bruel S, et al. The human colonic microflora influences the alterations of xenobiotic-metabolizing enzymes by catechins in male F344 rats. Food Chem Toxicol 2003;41(5):695-702
121. Pieper IA, Bertau M. Predictive tools for the evaluation of microbial effects on drugs during gastrointestinal passage. Expert Opin Drug Metab Toxicol 2010;6(6):747-60
122. Feria-Gervasio D, Tottey W, Gaci N, et al. Three-stage continuous culture system with a self-generated anaerobia to study the regionalized metabolism of the human gut microbiota. J Microbiol Methods 2014;96:111-18
123. Martin FP, Wang Y, Sprenger N, et al. Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model. Mol Syst Biol 2008;4:205-21
124. Holmes E, Li JV, Marchesi JR, et al. Gut microbiota composition and activity in relation to host metabolic phenotype and disease risk. Cell Metab 2012;16(5):559-64
125. van Zanten GC, Knudsen A, Roytio H, et al. The effect of selected synbiotics on microbial composition and short-chain fatty acid production in a model system of the human colon. PLoS One 2012;7(10):e47212
126. Everard A, Cani PD. Gut microbiota and GLP-1. Rev Endocr Metab Disord 2014;15(3):189-96
127. Monachese M, Burton JP, Reid G. Bioremediation and tolerance of humans to heavy metals through microbial processes: a potential role for probiotics? Appl Environ Microbiol 2012;78(18):6397-404
128. Zhai Q, Wang G, Zhao J, et al. Protective effects of Lactobacillus plantarum CCFM8610 against acute cadmium toxicity in mice. Appl Environ Microbiol 2013;79(5):1508-15
129. Bindels LB, Delzenne NM. Muscle wasting: the gut microbiota as a new therapeutic target? Int J Biochem Cell Biol 2013;45(10):2186-90
130. Smith DJ, Badrick AC, Zakrzewski M, et al. Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. Eur Respir J 2014;44(4):922-30
131. Cani PD, Geurts L, Matamoros S, et al. Glucose metabolism: Focus on gut microbiota, the endocannabinoid system and beyond. Diabetes Metab 2014;40(4):246-57
132. Muccioli GG, Naslain D, Backhed F, et al. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010;6:392
133. Muccioli GG. Endocannabinoid biosynthesis and inactivation, from simple to complex. Drug Discov Today 2010;15(11-12):474-83
134. Vrieze A, Out C, Fuentes S, et al. Impact of oral vancomycin on gut microbiota, bile acid metabolism, and insulin sensitivity. J Hepatol 2014;60(4):824-31
135. Wallace BD, Wang H, Lane KT, et al. Alleviating cancer drug toxicity by inhibiting a bacterial enzyme. Science 2010;330(6005):831-55
136. Huang C, Lei H, Zhao X, et al. Metabolic influence of acute cyadox exposure on Kunming mice. J Proteome Res 2013;12(1):537-45
137. Dethlefsen L, Eckburg PB, Bik EM, et al. Assembly of the human intestinal microbiota. Trends Ecol Evol 2006;21(9):517-23
138. Xiao S, Zhao L. Gut microbiota-based translational biomarkers to prevent metabolic syndrome via nutritional modulation. FEMS Microbiol Ecol 2014;87(2):303-14
139. Kotula JW, Kerns SJ, Shaket LA, et al. Programmable bacteria detect and record an environmental signal in the mammalian gut. Proc Natl Acad Sci USA 2014;111(13):4838-43
140. Wikoff WR, Anfora AT, Liu J, et al. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009;106(10):3698-703
141. Holmes E, Kinross J, Gibson GR, et al. Therapeutic modulation of microbiotahost metabolic interactions. Sci Transl Med 2012;4(137):137rv6
142. Li H, Jia W. Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity. Clin Pharmacol Ther 2013;94(5):574-81
143. Li M, Wang B, Zhang M, et al. Symbiotic gut microbes modulate human metabolic phenotypes. Proc Natl Acad Sci USA 2008;105(6):2117-22
144. Li T, Chiang JY. Nuclear receptors in bile acid metabolism. Drug Metab Rev 2013;45(1):145-55
145. Li T, Chiang JY. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 2014;66(4):948-83
146. Dull BJ, Salata K, Goldman P. Role of the intestinal flora in the acetylation of sulfasalazine metabolites. Biochem Pharmacol 1987;36(21):3772-37724
147. Sasaki I, Tamura T, Shibakawa T, et al. Metabolism of azetirelin, a newthyrotropin-releasing hormone (TRH)analogue, by intestinal microorganisms. Pharm Res 1997;14(8):1004-47
148. Iveson P, Lindup WE, Parke DV, et al. The metabolism of carbenoxolone in the rat. Xenobiotica 1971;1(1):79-95
149. Holt R. The bacterial degradation of chloramphenicol. Lancet 1967;1(7502):1259-60
150. Elmer GW, Remmel RP. Role of the intestinal microflora in clonazepam metabolism in the rat. Xenobiotica 1984;14(11):829-40
151. Viaud S, Saccheri F, Mignot G, et al. The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science 2013;342(6161):971-6
152. Rafii F, Hotchkiss C, Heinze TM, et al. Metabolism of daidzein by intestinal bacteria from rhesus monkeys (Macaca mulatta). Comp Med 2004;54(2):165-9
153. Lindenbaum J, Rund DG, Butler VP Jr, et al. Inactivation of digoxin by the gut flora: reversal by antibiotic therapy. N Engl J Med 1981;305(14):789-94
154. Harris BE, Manning BW, Federle TW, et al. Conversion of 5-fluorocytosine to 5-fluorouracil by human intestinal microflora. Antimicrob Agents Chemother 1986;29(1):44-8
155. Lee NK, Choi SH, Park SH, et al. Antiallergic activity of hesperidin is activated by intestinal microflora. Pharmacology 2004;71(4):174-80
156. Smith RV. Metabolism of drugs and other foreign compounds by intestinal microorganisms. World Rev Nutr Diet 1978;29:60-76
157. Tozaki H, Emi Y, Horisaka E, et al. Metabolism of peptide drugs by the microorganisms in rat cecal contents. Biol Pharm Bull 1995;18(6):929-31
158. Goldin BR, Peppercorn MA, Goldman P. Contributions of host and intestinal microflora in the metabolism of L-dopa by the rat. J Pharmacol Exp Ther 1973;186(1):160-6
159. Elkington SG, Floch MH, Conn HO. Control of chronic portal-systemic encephalopathy by lactulose. Gut 1969;10(5):416
160. Goldman P, Peppercorn MA, Goldin BR. Metabolism of drugs by microorganisms in the intestine. Am J Clin Nutr 1974;27(11):1348-55
161. Shu YZ, Kingston DG, van Tassell RL, et al. Metabolism of levamisole, an anticolon cancer drug, by human intestinal bacteria. Xenobiotica 1991;21(6):737-50
162. Caldwell J, Hawksworth GM. The demethylation of methamphetamine by intestinal microflora. J Pharm Pharmacol 1973;25(5):422-4
163. Valerino DM. Studies of the metabolism of methotrexate. II. Isolation and identification of several unconjugated aminopteridines as metabolites in the rat. Res Commun Chem Pathol Pharmacol 1972;4(3):529-42
164. Valerino DM, Johns DG, Zaharko DS, et al. Studies of the metabolism of methotrexate by intestinal flora. I. Identification and study of biological properties of the metabolite 4-amino-4-deoxy-N 10 -methylpteroic acid. Biochem Pharmacol 1972;21(6):821-31
165. Koch RL, Chrystal EJ, Beaulieu BB Jr, et al. Acetamide - a metabolite of metronidazole formed by the intestinal flora. Biochem Pharmacol 1979;28(24):3611-15
166. Koch RL, Beaulieu BB Jr, Goldman P. Role of the intestinal flora in the metabolism of misonidazole. Biochem Pharmacol 1980;29(24):3281-4
167. Walsh CT, Levine RR. Studies of the enterohepatic circulation of morphine in the rat. J Pharmacol Exp Ther 1975;195(2):303-10
168. Takeno S, Nakagawa M, Sakai T. Teratogenic effects of nitrazepam in rats. Res Commun Chem Pathol Pharmacol 1990;69(1):59-70
169. Basit AW, Newton JM, Lacey LF. Susceptibility of the H2-receptor antagonists cimetidine, famotidine and nizatidine, to metabolism by the gastrointestinal microflora. Int J Pharm 2002;237(1-2):23-33
170. Watanabe K, Yamashita S, Furuno K, et al. Metabolism of omeprazole by gut flora in rats. J Pharm Sci 1995;84(4):516-17
171. Smith RL, Timbrell JA. Factors affecting the metabolism of phenacetin. II. Effect of aspirin, caffeine, codeine, ethanol and phenobarbital on the metabolism of (acetyl-14C)-phenacetin in the rat. Xenobiotica 1974;4(8):503-8
172. Smith RL, Timbrell JA. Factors affecting the metabolism of phenacetin. I. Influence of dose, chronic dosage, route of administration and species on the metabolism of (1-14C-acetyl)phenacetin. Xenobiotica 1974;4(8):489-501
173. Fouts JR, Kamm JJ, Brodie BB. Enzymatic reduction of prontosil and other azo dyes. J Pharmacol Exp Ther 1957;120(3):291-300
174. Gingell R, Bridges JW, Williams RT. The role of the gut flora in the metabolism of prontosil and neoprontosil in the rat. Xenobiotica 1971;1(2):143-56
175. Schneider H, Simmering R, Hartmann L, et al. Degradation of quercetin-3-glucoside in gnotobiotic rats associated with human intestinal bacteria. J Appl Microbiol 2000;89(6):1027-37
176. Meuldermans W, Hendrickx J, Mannens G, et al. The metabolism and excretion of risperidone after oral administration in rats and dogs. Drug Metab Dispos 1994;22(1):129-38
177. Kobashi K, Nishimura T, Kusaka M, et al. Metabolism of sennosides by human intestinal bacteria. Planta Med 1980;40(3):225-36
178. Nakayama H, Kinouchi T, Kataoka K, et al. Intestinal anaerobic bacteria hydrolyse sorivudine, producing the high blood concentration of 5-(E)-(2-bromovinyl)uracil that increases the level and toxicity of 5-fluorouracil. Pharmacogenetics 1997;7(1):35-43
179. Evenson A, Mc CE, Geyer BR, et al. The cecal flora of white rats on a purified diet and its modification by succinylsulfathiazole. J Bacteriol 1946;51:513-21
180. Wadworth AN, Fitton A. Olsalazine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in inflammatory bowel disease. Drugs 1991;41(4):647-64
181. Strong HA, Renwick AG, George CF, et al. The reduction of sulphinpyrazone and sulindac by intestinal bacteria. Xenobiotica 1987;17(6):685-96
182. Kitamura S, Sugihara K, Kuwasako M, et al. The role of mammalian intestinal bacteria in the reductive metabolism of zonisamide. J Pharm Pharmacol 1997;49(3):253-6